Go Pro

Aimei Health Technology (AFJK) Competitors

Aimei Health Technology logo
$27.20 +0.20 (+0.73%)
Closing price 07/2/2026 03:54 PM Eastern
Extended Trading
$28.30 +1.11 (+4.07%)
As of 07/2/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AFJK vs. PINE, MSB, XRPN, CEPV, and VCIC

Should you buy Aimei Health Technology stock or one of its competitors? MarketBeat compares Aimei Health Technology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aimei Health Technology include Alpine Income Property Trust (PINE), Mesabi Trust (MSB), Armada Acquisition Corp. II (XRPN), Cantor Equity Partners V (CEPV), and Vine Hill Capital Investment (VCIC). These companies are all part of the "trading" industry.

How does Aimei Health Technology compare to Alpine Income Property Trust?

Aimei Health Technology (NASDAQ:AFJK) and Alpine Income Property Trust (NYSE:PINE) are both small-cap trading companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

45.6% of Aimei Health Technology shares are owned by institutional investors. Comparatively, 60.5% of Alpine Income Property Trust shares are owned by institutional investors. 2.5% of Aimei Health Technology shares are owned by insiders. Comparatively, 0.6% of Alpine Income Property Trust shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Alpine Income Property Trust has a net margin of 1.09% compared to Aimei Health Technology's net margin of 0.00%. Alpine Income Property Trust's return on equity of 0.25% beat Aimei Health Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Aimei Health TechnologyN/A -25.30% 3.22%
Alpine Income Property Trust 1.09%0.25%0.10%

In the previous week, Alpine Income Property Trust had 2 more articles in the media than Aimei Health Technology. MarketBeat recorded 2 mentions for Alpine Income Property Trust and 0 mentions for Aimei Health Technology. Alpine Income Property Trust's average media sentiment score of 0.03 beat Aimei Health Technology's score of 0.00 indicating that Alpine Income Property Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Aimei Health Technology Neutral
Alpine Income Property Trust Neutral

Aimei Health Technology has higher earnings, but lower revenue than Alpine Income Property Trust. Alpine Income Property Trust is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aimei Health TechnologyN/AN/A$1.06M$0.16169.98
Alpine Income Property Trust$60.53M5.62-$2.66M-$0.09N/A

Aimei Health Technology has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market. Comparatively, Alpine Income Property Trust has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market.

Alpine Income Property Trust has a consensus target price of $20.31, indicating a potential downside of 1.42%. Given Alpine Income Property Trust's stronger consensus rating and higher possible upside, analysts plainly believe Alpine Income Property Trust is more favorable than Aimei Health Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aimei Health Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Alpine Income Property Trust
0 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.73

Summary

Alpine Income Property Trust beats Aimei Health Technology on 10 of the 16 factors compared between the two stocks.

How does Aimei Health Technology compare to Mesabi Trust?

Mesabi Trust (NYSE:MSB) and Aimei Health Technology (NASDAQ:AFJK) are both small-cap trading companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

In the previous week, Mesabi Trust's average media sentiment score of 0.00 equaled Aimei Health Technology'saverage media sentiment score.

Company Overall Sentiment
Mesabi Trust Neutral
Aimei Health Technology Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mesabi Trust
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Aimei Health Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Mesabi Trust has a net margin of 75.32% compared to Aimei Health Technology's net margin of 0.00%. Mesabi Trust's return on equity of 54.83% beat Aimei Health Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Mesabi Trust75.32% 54.83% 46.67%
Aimei Health Technology N/A -25.30%3.22%

45.6% of Aimei Health Technology shares are owned by institutional investors. 0.3% of Mesabi Trust shares are owned by insiders. Comparatively, 2.5% of Aimei Health Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Mesabi Trust has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market. Comparatively, Aimei Health Technology has a beta of 0.55, indicating that its share price is 45% less volatile than the broader market.

Mesabi Trust has higher revenue and earnings than Aimei Health Technology. Mesabi Trust is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mesabi Trust$17.52M19.21$13.87M$0.8629.82
Aimei Health TechnologyN/AN/A$1.06M$0.16169.98

Summary

Mesabi Trust beats Aimei Health Technology on 7 of the 11 factors compared between the two stocks.

How does Aimei Health Technology compare to Armada Acquisition Corp. II?

Armada Acquisition Corp. II (NASDAQ:XRPN) and Aimei Health Technology (NASDAQ:AFJK) are both small-cap financial services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

In the previous week, Armada Acquisition Corp. II's average media sentiment score of 0.63 beat Aimei Health Technology's score of 0.00 indicating that Armada Acquisition Corp. II is being referred to more favorably in the media.

Company Overall Sentiment
Armada Acquisition Corp. II Positive
Aimei Health Technology Neutral

Armada Acquisition Corp. II's return on equity of 0.00% beat Aimei Health Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Armada Acquisition Corp. IIN/A N/A N/A
Aimei Health Technology N/A -25.30%3.22%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Armada Acquisition Corp. II
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Aimei Health Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

28.0% of Armada Acquisition Corp. II shares are held by institutional investors. Comparatively, 45.6% of Aimei Health Technology shares are held by institutional investors. 2.5% of Aimei Health Technology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Armada Acquisition Corp. IIN/AN/AN/AN/AN/A
Aimei Health TechnologyN/AN/A$1.06M$0.16169.98

Summary

Aimei Health Technology beats Armada Acquisition Corp. II on 3 of the 5 factors compared between the two stocks.

How does Aimei Health Technology compare to Cantor Equity Partners V?

Aimei Health Technology (NASDAQ:AFJK) and Cantor Equity Partners V (NASDAQ:CEPV) are both small-cap financial services companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

In the previous week, Cantor Equity Partners V had 9 more articles in the media than Aimei Health Technology. MarketBeat recorded 9 mentions for Cantor Equity Partners V and 0 mentions for Aimei Health Technology. Aimei Health Technology's average media sentiment score of 0.00 equaled Cantor Equity Partners V'saverage media sentiment score.

Company Overall Sentiment
Aimei Health Technology Neutral
Cantor Equity Partners V Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aimei Health Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Cantor Equity Partners V
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Cantor Equity Partners V's return on equity of 0.00% beat Aimei Health Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Aimei Health TechnologyN/A -25.30% 3.22%
Cantor Equity Partners V N/A N/A N/A

Cantor Equity Partners V is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aimei Health TechnologyN/AN/A$1.06M$0.16169.98
Cantor Equity Partners VN/AN/A$1.23M$0.07148.29

45.6% of Aimei Health Technology shares are held by institutional investors. 2.5% of Aimei Health Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Aimei Health Technology beats Cantor Equity Partners V on 5 of the 8 factors compared between the two stocks.

How does Aimei Health Technology compare to Vine Hill Capital Investment?

Aimei Health Technology (NASDAQ:AFJK) and Vine Hill Capital Investment (NASDAQ:VCIC) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

In the previous week, Aimei Health Technology's average media sentiment score of 0.00 equaled Vine Hill Capital Investment'saverage media sentiment score.

Company Overall Sentiment
Aimei Health Technology Neutral
Vine Hill Capital Investment Neutral

45.6% of Aimei Health Technology shares are owned by institutional investors. 2.5% of Aimei Health Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Vine Hill Capital Investment is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aimei Health TechnologyN/AN/A$1.06M$0.16169.98
Vine Hill Capital InvestmentN/AN/A$5.54M$0.1861.11

Aimei Health Technology's return on equity of -25.30% beat Vine Hill Capital Investment's return on equity.

Company Net Margins Return on Equity Return on Assets
Aimei Health TechnologyN/A -25.30% 3.22%
Vine Hill Capital Investment N/A -100.73%2.40%

Aimei Health Technology has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market. Comparatively, Vine Hill Capital Investment has a beta of 0.09, suggesting that its stock price is 91% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aimei Health Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Vine Hill Capital Investment
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Aimei Health Technology beats Vine Hill Capital Investment on 6 of the 8 factors compared between the two stocks.

Get Aimei Health Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for AFJK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AFJK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFJK vs. The Competition

MetricAimei Health TechnologyUNCLASSIFIED IndustryFinancial SectorNASDAQ Exchange
Market Cap$85.49M$159.18M$5.53B$12.48B
Dividend YieldN/AN/A5.23%6.52%
P/E Ratio169.9942.6030.0624.70
Price / SalesN/A230.251,118.6399.49
Price / Cash54.152,552.1989.0357.09
Price / Book-14.2438.526.686.46
Net Income$1.06M-$17.90M$1.13B$337.01M
7 Day Performance3.13%1.04%0.67%1.69%
1 Month Performance-29.61%-4.06%1.71%3.81%
1 Year Performance143.91%-1.88%25.01%23.90%

Aimei Health Technology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AFJK
Aimei Health Technology
0.2135 of 5 stars
$27.20
+0.7%
N/A+143.9%$85.49MN/A169.99N/A
PINE
Alpine Income Property Trust
2.457 of 5 stars
$20.61
-0.1%
$20.31
-1.4%
+38.4%$340.50M$64.73MN/AN/A
MSB
Mesabi Trust
1.3998 of 5 stars
$25.65
+0.2%
N/A+3.0%$336.49M$14.30M29.82N/A
XRPN
Armada Acquisition Corp. II
1.1081 of 5 stars
$10.45
flat
N/AN/A$330.12MN/AN/A2
CEPV
Cantor Equity Partners V
0.1354 of 5 stars
$10.38
flat
N/AN/A$329.98MN/A148.292

Related Companies and Tools


This page (NASDAQ:AFJK) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners